Nail Fungus Root Cause – Why Most Treatments Fail

Understanding the root cause of nail fungus is essential to treating it successfully. Dr. Kimberly Langdon explains why most conventional treatments fail — and what Kerassentials does differently.

The Fungal Species Behind Most Infections

Onychomycosis — toenail fungal infection — is caused primarily by dermatophytes, with Trichophyton rubrum accounting for approximately 70% of cases. These fungi thrive in warm, moist environments and feed on keratin — the primary structural protein of the nail. Understanding this helps explain why enclosed footwear and damp environments are the most common risk factors.

Why Conventional Topical Treatments Fail

Most over-the-counter nail antifungal products fail because they cannot deliver active ingredients through the nail plate in sufficient concentration to inhibit fungal growth at the nail bed. The nail plate is 0.5 to 0.7mm thick and highly resistant to penetration — most water-based topical treatments achieve less than 1% transungual delivery of active ingredients.

Why Oral Antifungals Have Limitations

Oral antifungals like terbinafine achieve high nail bed concentrations but carry systemic risks including liver toxicity, drug interactions, and the need for medical monitoring. They also have significant recurrence rates because they do not address the environmental and microbiome factors that allowed the infection to establish.

The Missing Element: Penetration Strategy

Dr. Langdon identified that the missing element in most topical treatments is a penetration strategy — a way to get the antifungal compounds through the nail plate to the infection site. The after shower hydration protocol and oil-based delivery of Kerassentials solve this specific problem.

Addressing Recurrence Risk

Long-term prevention of recurrence requires maintaining the local nail environment — good hygiene, moisture management, and continued antifungal support. Kerassentials’ nourishing formula supports ongoing nail and periungual skin health even after active infection has cleared, reducing recurrence risk.